Glaucoma: now and beyond

H Jayaram, M Kolko, DS Friedman, G Gazzard - The Lancet, 2023 - thelancet.com
The glaucomas are a group of conditions leading to irreversible sight loss and characterised
by progressive loss of retinal ganglion cells. Although not always elevated, intraocular …

The molecular aspect of anti-glaucomatous eye drops-are we harming our patients?

A Hedengran, M Kolko - Molecular Aspects of Medicine, 2023 - Elsevier
Glaucoma is one of the leading causes of irreversible blindness. Progression is halted with a
reduction in intraocular pressure (IOP), which is most often achieved with eye drops. A major …

[HTML][HTML] Glaucoma and ocular surface disease: more than meets the eye

G Li, EK Akpek, S Ahmad - Clinical Ophthalmology (Auckland, NZ), 2022 - ncbi.nlm.nih.gov
Understanding the association between ocular surface disease and glaucoma is important
for improving adherence to treatment and introducing practical solutions. While topical …

Adherence and persistence to medical therapy in glaucoma: An overview

L Quaranta, A Novella, M Tettamanti, L Pasina… - Ophthalmology and …, 2023 - Springer
Glaucoma is a group of progressive optic neuropathies characterized by loss of retinal
ganglion cells and visual field deterioration. Despite the fact that the underlying …

Comparison of ocular surface assessment and adherence between preserved and preservative-free latanoprost in glaucoma: a parallel-grouped randomized trial

DW Kim, J Shin, CK Lee, M Kim, S Lee, S Rho - Scientific Reports, 2021 - nature.com
Given that nonadherence is related to subject characteristics and drug tolerance and
preserved eye drops tend to be more intolerable than preservative-free ones, we conducted …

A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension

A Katsanos, I Riva, B Bozkurt, G Holló… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction In the last 25 years, topical prostaglandin analogues (PGAs) have emerged to
become first line and first choice therapeutic options in the management of glaucoma and …

Impact of latanoprost antiglaucoma eyedrops and their excipients on toxicity and healing characteristics in the ex vivo eye irritation test system

C Panfil, L Chauchat, C Guerin, H Rebika… - Ophthalmology and …, 2023 - Springer
Introduction Corneal epithelial toxicity and delayed healing process have already been
attributed to preservatives or some excipients. We study the effects of galenic components in …

[HTML][HTML] Is it time for a moratorium on the use of benzalkonium chloride in eyedrops?

L D'andrea, M Montemagni, G Celenza… - British Journal of …, 2022 - ncbi.nlm.nih.gov
Benzalkonium chloride (BAC) is a quaternary ammonium compound introduced in 1935 and
widely used as a skin and surface disinfectant and preservative in many household cleaning …

The PRAMOS Study: PRostaglandin Analogues Monotherapy—Awareness Survey on Ocular Surface Involvement

P Bastelica, JP Renard, F Aptel, A Labbé… - Ophthalmology and …, 2024 - Springer
Introduction Even though the local tolerance of prostaglandin (PG) analogues has improved
drastically since the introduction of preservative-free (PF) eye drops, prescription patterns …

FAST® questionnaire for identifying glaucoma patients at risk for ocular surface disease

C Baudouin, M Misiuk-Hojlo… - European Journal …, 2024 - journals.sagepub.com
Objectives To evaluate the validity and reliability of the new Fast Assessment of the Ocular
Surface Trouble (FAST®) questionnaire for identifying glaucoma or ocular hypertension …